The seventh presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The third presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The sixth presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The first presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The ninth and final presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
A brief tour of why we focused on building out a data warehouse early on at Clover, and why we think the Data Science function has room to grow in health insurance.
Gain insights from data analytics and take action! Learn why everyone is making a big deal about big data in healthcare and how data analytics creates action.
The third presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The sixth presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The first presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
The ninth and final presentation delivered at the 'Big Data in health and care: using data to gain new insights’ event, hosted by Wessex Academic Health Science Network (AHSN) on 19 April 2015.
A brief tour of why we focused on building out a data warehouse early on at Clover, and why we think the Data Science function has room to grow in health insurance.
Gain insights from data analytics and take action! Learn why everyone is making a big deal about big data in healthcare and how data analytics creates action.
This presentation looks at the role of Big Data with Healthcare. Healthcare is big spending area for both the private and public sector as such it is important to look at ways to improve the delivery of healthcare to patient care.
BIG Data & Hadoop Applications in HealthcareSkillspeed
Explore the applications of BIG Data & Hadoop in Healthcare via Skillspeed.
BIG Data & Hadoop in Healthcare is a key differentiator, especially in terms of providing superior patient care. They are used for optimizing clinical trials, disease detection & boosting healthcare profitability.
To get more details regarding BIG Data & Hadoop, please visit - www.SkillSpeed.com
With Attune’s Business Intelligence Solution for Labs harmonizing your operations data from billing, cash, remittance, procurement to performance, you can now monitor and forecast financial and operational performance more effectively. Mobile dashboards allow your executives to stay in touch with recent developments in the revenue cycle at all times.
While Healthcare 1.0 was broadly defined by a focus on defensive medicine, billing, and fee-for-service, culminating in the mass adoption of EMRs, Healthcare 2.0 is a new wave focused on improving clinical efficiency, quality of care, affordability, and fee-for-value; culminating in a new age of healthcare analytics. This new age of analytics will require a new set of organizational skills and a foundational set of analytic information systems that many executives have not anticipated.
Join Dale Sanders, a 20-year healthcare CIO veteran and the industry's leading analytics expert, as he discusses his lessons learned, best practices in analytics, and what the C-level suite needs to know about this topic, now. Listen to Dale discuss 1) A step-by-step curriculum for analytic adoption and maturity in healthcare organizations, 2) the basic approach to a late-binding data warehouse, 3) pros and cons of early versus late binding, 4) the volatility in vocabulary and business rules in healthcare, 5) how to engineer your data to accommodate volatility in the future
Delivering Analytic Insights from the Warehouse to the Front Lines: Your Most...Health Catalyst
As clinicians contend with having too much on their plates, they also rarely get all the information they need to be most effective. Meanwhile, your organization has an expansive amount of data—more data than anyone will ever read on even a single patient. Managing this data load to deliver just-in-time insights, decision support, and analytics is the key to supporting care teams and allowing them to focus on providing the best care to the patients in front of them.
What You'll Learn:
- Effective methods for delivering data to your providers.
- Building analytics into every workflow.
- Empowering your team with technology-driven clinical decision support.
- Streamlining your data delivery to provider better care, drive revenue, and make your system more efficient.
Data Quality Analytics: Understanding what is in your data, before using itDomino Data Lab
Analytics and data science are ever growing fields, as business decision makers continue to use data to drive decisions. The pinnacle of these fields are the models and their accuracy/fit,; what about the data? Is your data clean, and how do you know that? Our discussion will focus on best practices for data preprocessing for analytic uses. Beginning with essential distributional checks of a dataset to a propose method for automated data validation process during ETL for transactional data.
On Tuesday July 26, 2016 I presented at the Tableau 10 launch in front of approximately 1,000 people. The purpose was to explain how we'd been able to leverage Tableau for insights at GenesisCare. This is the presentation slide deck.
Supporting innovation in insurance with randomized experimentationDomino Data Lab
Recent technological advances, a dynamic competitive landscape, and an evolving regulatory environment have led to a period of rapid innovation for many insurance providers. Here, we’ll explore how data scientists may use randomized experiments to rigorously assess the causal impact of innovations on business outcomes. Particular emphasis will be placed on experimentation in “offline” channels, with some of the challenges and mitigation strategies highlighted.
Microsoft: A Waking Giant In Healthcare Analytics and Big DataHealth Catalyst
In 2005, Northwestern Memorial Healthcare embarked upon a strategic Enterprise Data Warehousing (EDW) initiative with the Microsoft technology platform as the foundation. Dale Sanders was CIO at Northwestern and led the development of Northwestern’s Microsoft-based EDW. At that time, Microsoft as an EDW platform was not en vogue and there were many who doubted the success of the Northwestern project. While other organizations were spending millions of dollars and years developing EDW’s and analytics on other platforms, Northwestern achieved great and rapid value at a fraction of the cost of the more typical technology platforms. Now, there are more healthcare data warehouses built around Microsoft products than any other vendor. The risky bet on Microsoft in 2005 paid off.
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
In this context, Dale will talk about:
His up and down journey with Microsoft as an Air Force and healthcare CIO, and why he is now more bullish on Microsoft like never before
A quick review of the Healthcare Analytics Adoption Model and Closed Loop Analytics in healthcare, and how Microsoft products relate to both
The rise of highly specialized, cloud-based analytic services and their value to healthcare organizations’ analytics strategies
Microsoft’s transformation from a closed-system, desktop PC company to an open-system consumer and business infrastructure company
The current transition period of enterprise data warehouses between the decline of relational databases and the rise of non-relational databases, and the new Microsoft products, notably Azure and the Analytic Platform System (APS), that bridge the transition of skills and technology while still integrating with core products like Office, Active Directory, and System Center
Microsoft’s strategy with its PowerX product line, and geospatial analysis and machine learning visualization tools
Big Data in Healthcare Made Simple: Where It Stands Today and Where It’s GoingHealth Catalyst
Health system leaders have questions about big data: When will I need it? How should I prepare? What’s the best way to use it? It’s important to separate the hype of big data from the reality. Where big data stands in healthcare today is a far cry from where it will be in the future. Right now, the best use cases are in academic- or research-focused healthcare institutions. Most healthcare organizations are still tackling issues with their transactional databases and learning how to use those databases effectively. But soon—once the issues of expertise and security have been addressed—big data will play a huge role in care management, predictive analytics, prescriptive analytics, and genomics for everyday patients. The transition to big data will be easier if health systems adopt a late-binding approach to the data now.
Outlines Watson accomplishments in 2012 and new products announced in early 2013. THIS DOCUMENT IS PROVIDED FOR REFERENCE PURPOSES ONLY. IBM RESERVES THE RIGHTS TO MAKE CHANGES TO THIS EVOLVING PORTFOLIO.
Data Lake vs. Data Warehouse: Which is Right for Healthcare?Health Catalyst
The data lake style of a data warehouse architecture is a flexible alternative to a traditional data warehouse. It allows for unstructured data. When a warehousing approach requires that the data be in a structured format, there are constraints on the analyses that can be performed because not all of the data can be structured early. The data lake concept is very similar to our Late-Binding approach in that data lakes are our source marts. We increase the efficiency and effectiveness of these through: 1. Metadata, 2. Source Mart Designer, and 3. Subject Area Mart Designer.
Levi Thatcher, Health Catalyst Director of Data Science and his team provide a live demonstration using healthcare.ai to implement a healthcare-specific machine learning model from data source to patient impact. Levi goes through a hands-on coding example while sharing his insights on the value of predictive analytics, the best path towards implementation, and avoiding common pitfalls. Frequently asked questions are answered during the session.
During the webinar, we will:
Describe and install healthcare.ai
Build and evaluate a machine learning model
Deploy interpretable predictions to SQL Server
Discuss the process of deploying into a live analytics environment.
If you’d like to follow along, you should download and install R and RStudio prior to the event. We look forward to you joining us!
A Health Catalyst Overview: Learn How a Data First Strategy Can Drive Increas...Health Catalyst
Without the pressure of a one-on-one demo, you can join a crowd of peers to ‘kick the tires’ if you will, as you listen to Jared Crapo—a sought after healthcare strategist—talk about what a data-first strategy is, and the strategic components to a data-first strategy employing a data operating system, a breakthrough engineering approach that combines the features of data warehousing, clinical data repositories, and health information exchanges in a single, common-sense technology platform that turns data into actionable assets used for all types of outcomes improvements.
Lest you worry about too much ‘pie in the sky’ strategy talk with few results to show, Sam Turman, Senior Solution Architect, will provide tangible solution demonstrations that are driving material results. Even if you aren’t in the market for Health Catalyst solutions and services, you will be able to:
Think with more clarity through your approach to overcoming the current market challenges.
Reconsider the strategy you are employing to build cross-organizational awareness and support to put a data-first plan at the center of your plan.
Define action you can take today to assess your gaps, understand your options, and accelerate your progress to drive outcomes improvements.
Join us and you won’t be disappointed. Jared is one of those types of thinkers that many pay big money to listen to and it is our fortune to have 60 minutes with him to think deeply about moving healthcare forward, one patient at a time. We hope you can join us.
A convection decay model for simulating the transmission of flood waves in ep...Amro Elfeki
Elfeki, A.M.M., Hatem A Ewea, Jarbou A Bahrawi, Nassir S Al-Amri: A Convection-Decay Model for Simulating the Transmission of Flood Waves in Ephemeral Channels in Arid Zones (2014). 6 International Conference on Water Resources and th Arid Environments (ICWRAE 6): 328-333, 16-17 December, 2014, Riyadh, Saudi Arabia.
This presentation looks at the role of Big Data with Healthcare. Healthcare is big spending area for both the private and public sector as such it is important to look at ways to improve the delivery of healthcare to patient care.
BIG Data & Hadoop Applications in HealthcareSkillspeed
Explore the applications of BIG Data & Hadoop in Healthcare via Skillspeed.
BIG Data & Hadoop in Healthcare is a key differentiator, especially in terms of providing superior patient care. They are used for optimizing clinical trials, disease detection & boosting healthcare profitability.
To get more details regarding BIG Data & Hadoop, please visit - www.SkillSpeed.com
With Attune’s Business Intelligence Solution for Labs harmonizing your operations data from billing, cash, remittance, procurement to performance, you can now monitor and forecast financial and operational performance more effectively. Mobile dashboards allow your executives to stay in touch with recent developments in the revenue cycle at all times.
While Healthcare 1.0 was broadly defined by a focus on defensive medicine, billing, and fee-for-service, culminating in the mass adoption of EMRs, Healthcare 2.0 is a new wave focused on improving clinical efficiency, quality of care, affordability, and fee-for-value; culminating in a new age of healthcare analytics. This new age of analytics will require a new set of organizational skills and a foundational set of analytic information systems that many executives have not anticipated.
Join Dale Sanders, a 20-year healthcare CIO veteran and the industry's leading analytics expert, as he discusses his lessons learned, best practices in analytics, and what the C-level suite needs to know about this topic, now. Listen to Dale discuss 1) A step-by-step curriculum for analytic adoption and maturity in healthcare organizations, 2) the basic approach to a late-binding data warehouse, 3) pros and cons of early versus late binding, 4) the volatility in vocabulary and business rules in healthcare, 5) how to engineer your data to accommodate volatility in the future
Delivering Analytic Insights from the Warehouse to the Front Lines: Your Most...Health Catalyst
As clinicians contend with having too much on their plates, they also rarely get all the information they need to be most effective. Meanwhile, your organization has an expansive amount of data—more data than anyone will ever read on even a single patient. Managing this data load to deliver just-in-time insights, decision support, and analytics is the key to supporting care teams and allowing them to focus on providing the best care to the patients in front of them.
What You'll Learn:
- Effective methods for delivering data to your providers.
- Building analytics into every workflow.
- Empowering your team with technology-driven clinical decision support.
- Streamlining your data delivery to provider better care, drive revenue, and make your system more efficient.
Data Quality Analytics: Understanding what is in your data, before using itDomino Data Lab
Analytics and data science are ever growing fields, as business decision makers continue to use data to drive decisions. The pinnacle of these fields are the models and their accuracy/fit,; what about the data? Is your data clean, and how do you know that? Our discussion will focus on best practices for data preprocessing for analytic uses. Beginning with essential distributional checks of a dataset to a propose method for automated data validation process during ETL for transactional data.
On Tuesday July 26, 2016 I presented at the Tableau 10 launch in front of approximately 1,000 people. The purpose was to explain how we'd been able to leverage Tableau for insights at GenesisCare. This is the presentation slide deck.
Supporting innovation in insurance with randomized experimentationDomino Data Lab
Recent technological advances, a dynamic competitive landscape, and an evolving regulatory environment have led to a period of rapid innovation for many insurance providers. Here, we’ll explore how data scientists may use randomized experiments to rigorously assess the causal impact of innovations on business outcomes. Particular emphasis will be placed on experimentation in “offline” channels, with some of the challenges and mitigation strategies highlighted.
Microsoft: A Waking Giant In Healthcare Analytics and Big DataHealth Catalyst
In 2005, Northwestern Memorial Healthcare embarked upon a strategic Enterprise Data Warehousing (EDW) initiative with the Microsoft technology platform as the foundation. Dale Sanders was CIO at Northwestern and led the development of Northwestern’s Microsoft-based EDW. At that time, Microsoft as an EDW platform was not en vogue and there were many who doubted the success of the Northwestern project. While other organizations were spending millions of dollars and years developing EDW’s and analytics on other platforms, Northwestern achieved great and rapid value at a fraction of the cost of the more typical technology platforms. Now, there are more healthcare data warehouses built around Microsoft products than any other vendor. The risky bet on Microsoft in 2005 paid off.
Ten years ago, critics didn’t believe that Microsoft could scale in the second generation of relational data warehouses, but they did. More recently, many of these same pundits have criticized Microsoft for missing the technology wave du jour in cloud offerings, mobile technology, and big data. But, once again, Microsoft has been quietly reengineering its culture and products, and as a result, they now offer the best value and most visionary platform for cloud services, big data, and analytics in healthcare.
In this context, Dale will talk about:
His up and down journey with Microsoft as an Air Force and healthcare CIO, and why he is now more bullish on Microsoft like never before
A quick review of the Healthcare Analytics Adoption Model and Closed Loop Analytics in healthcare, and how Microsoft products relate to both
The rise of highly specialized, cloud-based analytic services and their value to healthcare organizations’ analytics strategies
Microsoft’s transformation from a closed-system, desktop PC company to an open-system consumer and business infrastructure company
The current transition period of enterprise data warehouses between the decline of relational databases and the rise of non-relational databases, and the new Microsoft products, notably Azure and the Analytic Platform System (APS), that bridge the transition of skills and technology while still integrating with core products like Office, Active Directory, and System Center
Microsoft’s strategy with its PowerX product line, and geospatial analysis and machine learning visualization tools
Big Data in Healthcare Made Simple: Where It Stands Today and Where It’s GoingHealth Catalyst
Health system leaders have questions about big data: When will I need it? How should I prepare? What’s the best way to use it? It’s important to separate the hype of big data from the reality. Where big data stands in healthcare today is a far cry from where it will be in the future. Right now, the best use cases are in academic- or research-focused healthcare institutions. Most healthcare organizations are still tackling issues with their transactional databases and learning how to use those databases effectively. But soon—once the issues of expertise and security have been addressed—big data will play a huge role in care management, predictive analytics, prescriptive analytics, and genomics for everyday patients. The transition to big data will be easier if health systems adopt a late-binding approach to the data now.
Outlines Watson accomplishments in 2012 and new products announced in early 2013. THIS DOCUMENT IS PROVIDED FOR REFERENCE PURPOSES ONLY. IBM RESERVES THE RIGHTS TO MAKE CHANGES TO THIS EVOLVING PORTFOLIO.
Data Lake vs. Data Warehouse: Which is Right for Healthcare?Health Catalyst
The data lake style of a data warehouse architecture is a flexible alternative to a traditional data warehouse. It allows for unstructured data. When a warehousing approach requires that the data be in a structured format, there are constraints on the analyses that can be performed because not all of the data can be structured early. The data lake concept is very similar to our Late-Binding approach in that data lakes are our source marts. We increase the efficiency and effectiveness of these through: 1. Metadata, 2. Source Mart Designer, and 3. Subject Area Mart Designer.
Levi Thatcher, Health Catalyst Director of Data Science and his team provide a live demonstration using healthcare.ai to implement a healthcare-specific machine learning model from data source to patient impact. Levi goes through a hands-on coding example while sharing his insights on the value of predictive analytics, the best path towards implementation, and avoiding common pitfalls. Frequently asked questions are answered during the session.
During the webinar, we will:
Describe and install healthcare.ai
Build and evaluate a machine learning model
Deploy interpretable predictions to SQL Server
Discuss the process of deploying into a live analytics environment.
If you’d like to follow along, you should download and install R and RStudio prior to the event. We look forward to you joining us!
A Health Catalyst Overview: Learn How a Data First Strategy Can Drive Increas...Health Catalyst
Without the pressure of a one-on-one demo, you can join a crowd of peers to ‘kick the tires’ if you will, as you listen to Jared Crapo—a sought after healthcare strategist—talk about what a data-first strategy is, and the strategic components to a data-first strategy employing a data operating system, a breakthrough engineering approach that combines the features of data warehousing, clinical data repositories, and health information exchanges in a single, common-sense technology platform that turns data into actionable assets used for all types of outcomes improvements.
Lest you worry about too much ‘pie in the sky’ strategy talk with few results to show, Sam Turman, Senior Solution Architect, will provide tangible solution demonstrations that are driving material results. Even if you aren’t in the market for Health Catalyst solutions and services, you will be able to:
Think with more clarity through your approach to overcoming the current market challenges.
Reconsider the strategy you are employing to build cross-organizational awareness and support to put a data-first plan at the center of your plan.
Define action you can take today to assess your gaps, understand your options, and accelerate your progress to drive outcomes improvements.
Join us and you won’t be disappointed. Jared is one of those types of thinkers that many pay big money to listen to and it is our fortune to have 60 minutes with him to think deeply about moving healthcare forward, one patient at a time. We hope you can join us.
A convection decay model for simulating the transmission of flood waves in ep...Amro Elfeki
Elfeki, A.M.M., Hatem A Ewea, Jarbou A Bahrawi, Nassir S Al-Amri: A Convection-Decay Model for Simulating the Transmission of Flood Waves in Ephemeral Channels in Arid Zones (2014). 6 International Conference on Water Resources and th Arid Environments (ICWRAE 6): 328-333, 16-17 December, 2014, Riyadh, Saudi Arabia.
Is My Digital Marketing Strategy Still Relevant in 2016?Capstrat
Shift and disruption are driving the digital industry. Technology advances continue to be a moving target. Learn how digital marketing continues to evolve, and get tips for refining your digital marketing strategy in 2016.
Utilities on social: 4 crisis tips for community managers Capstrat
When a crisis happens, the first resource customers turn to is social media. They expect up-to-date information, help and solutions. For a utility in a weather crisis, this means lots of unhappy customers searching for a solution to a problem we have little to no control over solving.
The worst thing a utility can do is be unprepared to respond on social media when a crisis hits. Planning responses, approval processes and even staffing is critical to success.
This slide deck provides four tips to help community managers:
- Humanize the brand
- Leverage internal expertise
- Divide and conquer customer service
- Provide transparent, timely information
Better Living Through Analytics - Strategies for Data DecisionsProduct School
Data is king! Get ready to understand how a successful analytics team can empower managers from product, marketing, and other areas to make effective, data-driven decisions.
Louis Cialdella, a data scientist at ZipRecruiter, shared some case studies and successful strategies that he has used at ZipRecruiter as well as previous experiences. The purpose of this data talk was to enlighten people on how to make sure that analysts can successfully partner with other departments and get them the information they need to do great things.
Methods of Forecasting for Capacity ManagementPrecisely
Forecasting is the process of making statements about events in the future. Events related to capacity management are typically things like the state of resource consumption, service levels, and computing environment changes at future points in time. Making statements or predictions about these future events requires analysis of information to determine a future state. Knowing what information is needed to make accurate forecasts is a critical step for any analysis.
Forecasts are made to answer questions. Understanding the questions, and things that affect answers to those questions, is the first step to creating an accurate forecast. Required accuracy of a forecast should determine which methods are used to create it. Assumptions can be made to limit the amount of data and time required for creating forecasts. Validating forecast accuracy, after events happen, is an important part of continually improving future forecasts, and building credibility. This webinar describes the important task of forecasting as it relates to capacity management.
This presentation covers the following topics:
• Why do we forecast?
• Forecasting scenarios
• Forecasting Techniques
• Forecasting and Virtualization
• Summary
See how you can use statistical analysis to conduct useful and effective consumer and marketing research. These slides were used in a seminar held in the UK at The Shard. To see upcoming seminars, visit http://www.jmp.com/uk/about/events/conferences/
Data Sourcing Best Practices for Reporting (Webinar slides)Yellowfin
Why watch?
Are you trapped in reporting hell?
Do you spend hours struggling to manually produce the reports management demands? Are you working with disparate islands of outdated data? And, after all that hard work, are the reports produced inaccurate and untrustworthy?
Watch this on-demand Webinar from SolveXia and Yellowfin – Data Sourcing Best Practices for Reporting – to discover how to build reliable supply chains of data in just 30-minutes. Learn how to quickly and easily go from source data to killer report – every time.
Only dependable and repeatable processes can produce quality data and reports. Ensure your reporting generates the business insights you need. Let SolveXia and Yellowfin show you how.
What will you learn?
Think the ability to deliver world-class, up-to-date and accurate reports that anyone can access, analyze and act on is important? Then this Webinar is a must.
Watch the on-demand version to learn how to:
•Create business critical reports on which you and your organization can rely
•Deliver sleek, sexy and intuitive charts, reports and dashboards to anyone, anywhere, anytime on any device
•Become the information Superhero you were meant to be!
The data that underpins any reporting system must be managed properly to make sure it’s clean, relevant and delivered in a timely manner to maximize the ability of enterprise BI solutions to produce actionable insights. Do you know how?
Presentation by Fiona Lord, Manager, WRaPT Service Lancashire Care NHS FT at the Workforce Resource Optimisation Big Innovation Conversation webinar on Thursday 14 March.
Physician schedule optimization model - Endeavor AnalyticsEndeavor Management
How can you meet organizational revenue needs while addressing physician preferences? In this presentation, we review our approach to creating an physician schedule optimization model that assembles and predicts the impact of schedule changes on patient revenue against a series of constraints and variables.
It's like a dating site to match physicians and consumers.
Colin Lewry and Fiona Lord - ECO 18: How digital innovation can support workf...Innovation Agency
Presentation by Colin Lewry, WRaPT Director and Fiona Lord, WRaPT Manager, Lancashire Care NHS Foundation Trust at ECO 18: How digital innovation can support workforce strategies on Wednesday 27 March at Haydock Park Racecourse.
Electrical distributors have been collecting data on product sales and customer orders for years now. But, technology now allows for the collection, synthesis and analysis of information like never before. Under the guise of Big Data, many industries are planning and even projecting outcomes. Most distributors are only utilizing ERP data, but at what cost? This white paper walks through how members of the electrical distribution channel can plan and execute big data projects to maximize not only sales, but also stock, logistics and customer satisfaction.
Business is running ever faster—generating, collecting and using increas-ing volumes of data about every aspect of the interactions between sup-pliers, manufacturers, retailers and customers. Within these mountains of data are seams of gold—patterns of behavior that can be interpreted, classified and analyzed to allow predictions of real value. Which treat-ment is likely to be most effective for this patient? What can we offer that this particular customer is more likely to buy? Can we identify if that transaction is fraudulent before the sale is closed?
Big Data Analytics for Healthcare Decision Support- Operational and ClinicalAdrish Sannyasi
Splunk’s data analytics platform could be utilized to solve many high impact business problems in healthcare delivery systems to reduce cost, improve patient outcome and safety, and enhance care coordination experience. Analyze observed behavior from healthcare event data and metadata to discover patterns, monitor compliance, and optimize the workflow. Furthermore 80% of healthcare data is unstructured (clinical free text and documentation), or semi-structured and many new data sources are such as tele health, mobile health, sensors, and devices are getting integrated in many healthcare systems specifically in the area of chronic disease management. So, one need analytics software that can harvest, interpret, enrich, normalize, and model diverse structured and unstructured data and analytics approaches that embrace the “data turmoil” by relying less on standardized data items and more on the capability to process data in any format.
Summer Shorts: Using Predictive Analytics For Data-Driven Decisionsibi
Predictive analytics has gained a lot of attention in recent years, enabling organizations to make better, faster, and more accurate business decisions. These decisions are applied across virtually all industries to generate revenue, reduce costs and risks, and improve processes.
See the pre-recorded webcast online at: http://www.informationbuilders.com/webevents/online/24374#sthash.FoJkEyuL.dpuf
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing opioid prescribing, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Pharmacist Interventions and Medication Reviews at Care Homes - Improving Med...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Pharmacist Interventions and Medication Reviews at Care Homes - Improving Medication Safety and Patient Outcomes, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, SBAR Patient Engagement Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Reducing medication related falls risk in patients with severe frailty, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Assessing the outcomes of structured medication reviews, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy SMR reviews in outpatient bone health clinics, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medic...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Polypharmacy reviews of asthma and COPD patients over 65 and 10 or more medicines, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Evaluating the impact of a specialist frailty multidisciplinary team pathway ...Health Innovation Wessex
The Health Innovation Network Polypharmacy Programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Evaluating the impact of a specialist frailty multidisciplinary team pathway with clinical pharmacist involvement, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Genome UK – State of the nation by Professor Dame Sue Hill, Chief Scientific Officer for England and NHS Genomics Programme Senior Responsible Officer.
Pharmacogenomics into practice - stroke services and a systems approach by Dr Richard Marigold, Consultant Stroke Physician and NIHR Hyperacute Stroke Research Centre Lead, University Hospital Southampton NHS Foundation Trust
To evaluate the benefits of Structured Medication Reviews in elderly Chinese ...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, To evaluate the benefits of Structured Medication Reviews in elderly Chinese patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary,
Review of patients on high dose opioids at Living Well PCN, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Re-establishing autonomy in elderly frail patients, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving Medication Reviews using the NO TEARS Tool, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Improving care in County Durham under the STOMP agenda - A 5 year review.pdfHealth Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Improving care in County Durham under the STOMP agenda - A 5 year review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Impact of an EMIS search to prioritise care home residents for a pharmacist l...Health Innovation Wessex
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Impact of an EMIS search to prioritise care home residents for a pharmacist led medication review, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
The Health Innovation Network Polypharmacy programme is working with healthcare professionals to address problematic polypharmacy by supporting easier identification of patients at potential risk from harm from multiple medications.
Our evidence-based polypharmacy Action Learning Sets (ALS) are being rolled out across England to support GPs, pharmacists and other healthcare professionals who undertake prescribing or medication reviews to understand the complex issues around stopping inappropriate medicines safely.
To drive and accelerate changes in practice, delegates complete a quality improvement project to address problematic polypharmacy in their workplace. This poster summary, Identifying Orthostatic Hypotension caused by Medication, can be viewed here.
For more information about the polypharmacy programme, please visit https://thehealthinnovationnetwork.co.uk/programmes/medicines/polypharmacy/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874